CN | EN | PHONE

Company Profile

   


Shijiazhuang Rainbowlabs pharmaceutical Technology Co. Ltd (Rainbowlabs) is a FDA-inspected laboratory which is set up to provide high quality standard laboratory testing services to pharmaceutical companies worldwide.
Rainbowlabs has received the highest accreditation from the U.S. FDA, Health Canada, ISO and CNAS over the past few years. With complete release test, R&D and cGMP auditing capabilities, we are committed to continuously improve the quality management and productivity of the global pharmaceutical industry.
We are experienced in contract testing, R&D, and toll manufacturing of APIs and new formulations.
 
In Dec.2011, Rainbowlabs received ISO9001 & UKAS certificate
In 2012, Rainbowlabs received GSP certificate
In Dec.2011, Rainbowlabs successfully passed U.S. FDA inspection with Zero 483 and acquired the qualification of third party testing laboratory.
In 2014, Rainbowlabs was approved by Health Canada
In Nov.2014, Rainbowlabs received CNAS certificate
In Jun.2016, Rainbowlabs successfully passed U.S. FDA reinspection with Zero 483
 
Rainbowlabs also offers QA and regulatory solutions including DMF/VMF/EDMF filing, source qualification, cGMP auditing, CAPA, and quality engineering management, supported by our highly qualified and experienced team.  We are proud to have obtained numerous successful FDA approvals of our contract API manufacturers since 2009.
 
In Sep. 2009, we helped our contract manufacturer of Lincomycin HCl, NCPC Huanluan, successfully pass their U.S.FDA audit with Zero 483.
In 2012, we helped our contract manufacturer Chongqing South West No.2 Pharmaceutical successfully pass their U.S.FDA inspection.
In Oct. 2012, our on-site QA and regulatory support helped CSPC Zhongrun successfully pass their U.S. FDA inspection for Penicillin G Potassium.
In 2013, we helped our contract manufacturer Hebei Jianmin successfully passing their U.S.FDA inspection.
In Aug. 2014, our contract manufacturer Ningxia Tairui successfully passed their U.S. FDA inspection for Tylosin Tartrate with our strong support and guidance.
In 2015, we successfully helped our contract manufacturers Inner Mongolia Changsheng and Livzon New North River pass their FDA inspection.
In 2016, we successfully helped our contract manufacturers NCPC Aino, Chonqing Southwest No. 2, Hebei Jianmin, Ningxia Tairui, Hubei Yitai pass their FDA inspection.